Table 2.
Time-related metrics of andexanet administration.
| Variable | TCS-based CS | p-value | |
|---|---|---|---|
| Yes (n = 17) | No (n = 25) | ||
| Onset-to-door time, min* | 148 (52–442) | 102 (50–430) | 0.64 |
| Door-to-imaging time, min | 10 (5–15) | 20 (13–40) | <0.01 |
| Door-to-CBC time, min† | 14 (8–20) | – | – |
| Imaging-to-andexanet administration time, min | 69 (62–102) | 100 (67–151) | 0.06 |
| Door-to-andexanet administration time, min | 90 (73–109) | 132 (99–195) | <0.01 |
| Onset-to-andexanet administration time, min* | 228 (132–500) | 292 (180–576) | 0.23 |
Data are presented as median (interquartile range). CBC, complete blood count; CS, code stroke; TCS, Task Calculation Stroke. *Onset-to-door and onset-to-andexanet administration times were available for 39 patients. †Door-to-CBC time was available only in patients with TCS-based CS.